Vesica Health, Inc.

IRVINE, CA · Founded 2022 · CIK 0002114321 · Medtech · Acquired

Noninvasive urine-based genomic test for bladder cancer risk stratification in hematuria patients

vesicahealth.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$4.5M
1 Form D · Mar 2026
7 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$4,467,683
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1663Resensys, LLC——
1664BARATI MEDICAL, LLC——
1665IMAGEAID, INC.—$200K
1666Vesica Health, Inc.—$4.5M
1667PERSISTA BIO INC—
1668Wisdom.io Inc.—$50K
1669CELLECTGEN, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Laura CabaExecutive Officer
  • Jan GroenDirector
  • Mark McDonoughDirector
  • Joseph SolleeDirector
  • Christopher ThibodeauDirector · Executive Officer

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.